Woo-Suk Tae

Woo-Suk Tae

Auto-generated profile, based on publicly available information

Woo-Suk Tae

Brain Convergence Research Center, Korea University, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2017 in Scientific Reports
Verified
Journal Article
Open access
KHKyu-Man Han
Kyu-Man Han
EWEunsoo Won
Eunsoo Won
YSYoungbo Sim
Youngbo Sim
JKJune Kang
June Kang
CHChangsu Han
Changsu Han
BHByung-Joo Ham
Byung-Joo Ham
A single nucleotide polymorphism of rs1360780 in the FKBP5 gene is associated with a predisposition to developing major depressive disorder (MDD). We investigated the interactive effects of FKBP5 rs1360780 allelic variants, DNA methylation, and the diagnosis of MDD on structural changes of the entire brain. One hundred and fourteen patients with MDD and eighty-eight healthy controls underwent T1-weighted structural magnetic resonance imaging and FKBP5 rs1360780 genotyping, including DNA methylation of intron 7. We analyzed the volume of cortical and subcortical regions and cortical thickness using FreeSurfer. Significant genotype-by-diagnosis interactions were observed for volumes of the left pars triangularis, supramarginal gyrus, superior parietal lobule, right frontomarginal, and posterior midcingulate gyrus. The T allele was associated with significant volume reductions in these brain regions only in the MDD group except for the right posterior midcingulate gyrus. FKBP5 DNA methylation showed a positive correlation with the thickness of the right transverse frontopolar gyrus in the C allele homozygote group. Our findings suggest that the FKBP5 gene and its epigenetic changes could have influence on morphologic changes of several brain regions involved in emotion regulation, and that this process may be associated with the development of MDD.

1 October 2017 in Journal of Psychiatric Research
Verified
Journal Article
Closed access
KHKyu-Man Han
Kyu-Man Han
EWEunsoo Won
Eunsoo Won
JKJune Kang
June Kang
SCSunyoung Choi
Sunyoung Choi
AKAram Kim
Aram Kim
BHByung-Joo Ham
Byung-Joo Ham

3 November 2016 in Human Brain Mapping
Verified
Journal Article
Closed access
KHKyu-Man Han
Kyu-Man Han
EWEunsoo Won
Eunsoo Won
JKJune Kang
June Kang
AKAram Kim
Aram Kim
HYHo‐Kyoung Yoon
Ho‐Kyoung Yoon
BHByung-Joo Ham
Byung-Joo Ham

23 March 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SBSeol-Hee Baek
Seol-Hee Baek
JPJinseok Park
Jinseok Park
YKYoo Hwan Kim
Yoo Hwan Kim
HSHung Youl Seok
Hung Youl Seok
KOKi-Wook Oh
Ki-Wook Oh
BKByung-Jo Kim
Byung-Jo Kim
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease. However, no reliable biomarkers have been identified to represent the clinical status. This study aimed to investigate whether diffusion tensor imaging (DTI) findings are useful imaging biomarkers to indicate the clinical status of ALS patients. Ninety-six probable or definite ALS cases and 47 age- and sex-matched, normal controls were enrolled. Demographic and clinical data were collected at the time of DTI. DTI data were acquired using a 3-Tesla magnetic resonance imaging scanner and analysed by voxel-wise statistical analyses for fractional anisotropy, axial diffusivity, radial diffusivity, mean diffusivity, and mode of anisotropy. Compared with the healthy control group, the ALS group had significant differences in DTI scalars in the diffuse tracts of the brain, which was predominant in the corticospinal tract at the brainstem and cerebellar peduncle area. Furthermore, the DTI values correlated with the ALS functional rating scale-revised (ALSFRS-R) scores and the delta ALSFRS-R score representing the rate of disease progression. The subgroup analysis revealed a more severe and widespread brain degeneration was observed in rapidly progressive ALS. Therefore, our results suggest that DTI findings are useful as imaging biomarkers for evaluating the clinical severity and rate of disease progression in ALS.

1 January 2025 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
WTWoo-Suk Tae
Woo-Suk Tae
BHByung-Joo Ham
Byung-Joo Ham
APand Sung-Bom Pyun
and Sung-Bom Pyun
BKByung-Jo Kim
Byung-Jo Kim
Tae WS, et al. J Clin Neurol. 2025 Jul;21(4):277-293. https://doi.org/10.3988/jcn.2025.0185

31 October 2022 in Experimental Neurobiology
Verified
Journal Article
Open access
PDF file
SSSeung-Joon Shin
Seung-Joon Shin
AKAram Kim
Aram Kim
KHKyu-Man Han
Kyu-Man Han
WTWoo-Suk Tae
Woo-Suk Tae
BHByung-Joo Ham
Byung-Joo Ham
Seung-Joon Shin, Aram Kim, Kyu-Man Han, Woo-Suk Tae and Byung-Joo Ham. Exp Neurobiol 2022;31:353-60. https://doi.org/10.5607/en22031